LB Pharmaceuticals Inc

LBRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Jun 9, 2026
424B3 Jun 9, 2026 424B3
8-K Jun 9, 2026 8-K
4 Jun 5, 2026
4 Jun 5, 2026
4 Jun 5, 2026
4 Jun 5, 2026
4 Jun 5, 2026
4 Jun 5, 2026
4 Jun 5, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G May 15, 2026
SCHEDULE 13G/A May 13, 2026
424B3 May 12, 2026 424B3
10-Q May 12, 2026 10-Q
8-K May 12, 2026 8-K
ARS Apr 23, 2026 ARS
DEFA14A Apr 23, 2026 DEFA14A
DEF 14A Apr 23, 2026 DEF 14A
EFFECT Apr 14, 2026
424B3 Apr 14, 2026 424B3
CORRESP Apr 10, 2026
UPLOAD Apr 10, 2026
S-1 Apr 6, 2026 S-1
← Newer Page 2 of 6 · 141 filings Older →